Institut Curie: all 134 studies
Page 2 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV)TerminatedNCT02554565Not applicable
- Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKidsCompletedNCT02546453Not applicable
- Characterisation of Biofilm of the Chronic WoundsCompletedNCT02519166Not applicable
- PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)TerminatedNCT02438761Phase 2
- Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)CompletedNCT02428842Not applicable
- MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer SurgeryCompletedNCT02408393Phase 3
- Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast CancerTerminatedNCT02250118Phase 1
- A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)CompletedNCT02244125Phase 2
- Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral PathologyCompletedNCT02220556Not applicable
- Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic WoundsTerminatedNCT02028923Phase 3
- Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.CompletedNCT01975142Phase 2
- Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System LymphomaCompletedNCT01956695Phase 2
- Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)TerminatedNCT01956552Not applicable
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)CompletedNCT01868269Phase 3
- A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory CancerCompletedNCT01771458Phase 2
- Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast CancersStatus unknownNCT01710605Phase 3
- Post-occlusive Reactive Hyperemia and Basal-cell CarcinomaCompletedNCT01455363Not applicable
- Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or DocetaxelCompletedNCT01448759Not applicable
- Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisCompletedNCT01373710Phase 1/2
- Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)CompletedNCT01351870Phase 3
- Study of Circulating Tumoral DNA in Ovarian CancerCompletedNCT01350908Not applicable
- Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast CancerCompletedNCT01349842Phase 3
- Study of Circulating Tumoral DNA in Metastatic Choroidal MelanomaCompletedNCT01334008Not applicable
- Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeStatus unknownNCT01217398Phase 2
- Study of Blood Samples From Patients With Ewing Sarcoma and Their RelativesCompletedNCT01210209
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical CancerCompletedNCT00957411Phase 2
- Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast CancerCompletedNCT00898014
- Study of Tumor and Blood Samples From Women With Breast CancerStatus unknownNCT00897728
- Bone Marrow and Blood Samples From Patients With Metastatic Choroid MelanomaCompletedNCT00897624
- Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast CancerStatus unknownNCT00875355Phase 2
- Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young PatientsActive, not recruitingNCT00863460Phase 2
- Test Semiquantitative Prostate Specific Antigen (PSA)CompletedNCT00853710Not applicable
- Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
- Chlorhydrate of Ropivacaine and Breast Cancer SurgeryCompletedNCT00370240Phase 4